Skip to main content
. 2022 Aug 20;8:95. doi: 10.1038/s41523-022-00468-0

Fig. 4. Relationship of pCR and RD with EFS in TNBC.

Fig. 4

pCR pathological complete response; RD residual disease; EFS event-free survival; TNBC triple negative breast cancer.